Abstract:Podophyllotoxin has long been used as an active substance for cytotoxic activity. Fourteen novel biotinylated podophyllotoxin derivatives were designed, synthesized, and evaluated for cytotoxic activity for this study. The synthesized compounds were evaluated for cytotoxic activity in the following human cancer cell lines, SW480, MCF-7, A-549, SMMC-7721, and HL-60 by MTT assay. Most of them exhibited potent cytotoxic effects and compound 15 showed the highest cytotoxic activity among the five cancer cell lines tested, having its IC50 values in the range of 0.13 to 0.84 μM. Apoptosis analysis revealed that compound 15 caused obvious induction of cell apoptosis. Compound 15 significantly down-regulated the expression level of the marker proteins (caspase-3 and PARP) in H1299 and H1975 cells, activated the transcription of IRE1α, increased the expression of GRP78 and XBP-1s, and finally induced apoptosis of H1299 cells. In vivo studies showed that 15 at a dose of 20 mg/kg suppressed tumor growth of S180 cell xenografts in icr mice significantly. Further molecular docking studies suggested that compound 15 could bind well with the ATPase domain of Topoisomerase-II. These data suggest that compound 15 is a promising agent for cancer therapy deserving further research.

Synthesis and Biological Evaluation of New 4Β-Anilino-4′-o-demethyl-4-desoxypodophyllotoxin Derivatives As Potential Antitumor Agents

Synthesis And Evaluation Of New Podophyllotoxin Derivatives With In Vitro Anticancer Activity

Synthesis of New Spin Labeled Derivatives of Podophyllotoxin As Potential Anticancer Agents

Synthesis and biological evaluation of novel podophyllotoxin analogs as antitumor agents.

Synthesis and Evaluation of Novel Podophyllotoxin Derivatives As Potential Antitumor Agents.

Synthesis and Biological Evaluation of 4Β-N-acetylamino Substituted Podophyllotoxin Derivatives As Novel Anticancer Agents.

Design, Synthesis and Potent Cytotoxic Activity of Novel Podophyllotoxin Derivatives.

Design, Synthesis and Cytotoxic Activity of Novel Sulfonylurea Derivatives of Podophyllotoxin

Syntheses and structure-activity relationship of podophyllotoxin derivatives as potential anticancer drugs

Novel 4β-anilino-podophyllotoxin derivatives: design synthesis and biological evaluation as potent DNA-topoisomerase II poisons and anti-MDR agents

Synthesis and anticancer activity of new derivatives of podophyllotoxin

Novel 4 beta-anilino-podophyllotoxin derivatives: design synthesis and biological evaluation as potent DNA-topoisomerase II poisons and anti-MDR agents.

Synthesis of Novel Spin-Labeled Podophyllotoxin Derivatives As Potential Antineoplastic Agents: Part XXV

Synthesis and Biological Evaluation of Derivatives of 4-Deoxypodophyllotoxin As Antitumor Agents.

Synthesis and Antitumor Activity of Novel Podophyllotoxin Derivatives Against Multidrug-Resistant Cancer Cells

Synthesis and Evaluation of Novel Podophyllotoxin Analogs

Synthesis and Evaluation of the Cell Cycle Arrest and CT DNA Interaction Properties of 4Β-Amino-4′-o-demethyl-4-deoxypodophyllotoxins

Synthesis and Biological Evaluation of New 4β-5-Fu-substituted 4'-Demethylepipodophyllotoxin Derivatives

Design, Synthesis, and Biological Evaluation of Novel Biotinylated Podophyllotoxin Derivatives as Potential Antitumor Agents

One-pot Synthesis and Biological Evaluation of N-(aminosulfonyl)-4-podophyllotoxin Carbamates As Potential Anticancer Agents.

Design, synthesis and biological evaluation of novel podophyllotoxin derivatives bearing 4 beta-disulfide/trisulfide bond as cytotoxic agents